{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:10:07Z","timestamp":1789189807585,"version":"build-2803163510"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>For diabetic patients with multivessel coronary artery disease (MVD), limited data exist on the long-term outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) according to clinical presentation [stable coronary artery disease (SCAD) or non-ST-elevation acute coronary syndrome (NSTE-ACS)].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and methods<\/jats:title>\n            <jats:p>From a Korean multicenter registry, we analyzed 1135 diabetic patients with MVD treated with PCI (<jats:italic toggle=\"yes\">n<\/jats:italic>\u2009=\u2009660) or CABG (<jats:italic toggle=\"yes\">n<\/jats:italic>\u2009=\u2009475). After propensity score matching, 8-year major adverse cardiovascular and cerebrovascular events [MACCE; composite of all-cause death, myocardial infarction (MI), or stroke] were compared between PCI and CABG according to clinical presentation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After matching, MACCE was not different between PCI and CABG for SCAD patients [15.6 vs. 17.2%, hazard ratio (HR) \u2009=\u20090.94, 95% confidence interval (CI) \u2009=\u20090.55\u20131.63, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.837], whereas it was higher in PCI than in CABG for NSTE-ACS patients (31.1 vs. 22.4%, HR\u2009=\u20091.63, 95% CI\u2009=\u20091.03\u20132.59, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.036), mainly driven by the higher MI occurrence (HR\u2009=\u20092.18, 95% CI\u2009=\u20091.04\u20134.59, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.035). A significant interaction between revascularization strategy and clinical presentation was observed for MACCE (<jats:italic toggle=\"yes\">P<\/jats:italic>-interaction\u2009=\u20090.022). However, when PCI was further classified according to revascularization completeness, the treatment gap between PCI and CABG with respect to MI in NSTE-ACS patients was improved by complete-revascularization PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Among diabetic patients with MVD, the long-term outcomes of PCI versus CABG differed according to clinical presentation. CABG may be more beneficial for NSTE-ACS patients with MVD in reducing MACCE and MI, whereas PCI was as effective as CABG for SCAD patients with MVD. Therefore, clinical presentation must be considered when choosing revascularization strategies in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000767","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T08:49:13Z","timestamp":1561020553000},"page":"174-183","source":"Crossref","is-referenced-by-count":7,"title":["Long-term outcomes after percutaneous coronary intervention relative to bypass surgery in diabetic patients with multivessel coronary artery disease according to clinical presentation"],"prefix":"10.1097","volume":"31","author":[{"given":"Yong-Joon","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghoon","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, National Health Insurance Service Ilsan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsung","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, Myongji Hospital, Goyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230924","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"R2-20230924","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0735-1097(00)00732-4","article-title":"Management of coronary artery disease: therapeutic options in patients with diabetes.","volume":"36","author":"Hammoud","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230924","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2337\/diacare.20.6.935","article-title":"A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.","volume":"20","author":"Folsom","year":"1997","journal-title":"Diabetes Care"},{"key":"R4-20230924","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0195-668X(03)00197-0","article-title":"Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study.","volume":"24","author":"Becker","year":"2003","journal-title":"Eur Heart J"},{"key":"R5-20230924","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.acvd.2014.03.003","article-title":"Distribution of coronary artery disease severity and risk factors in Afro-Caribbeans.","volume":"107","author":"Larifla","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"R6-20230924","first-page":"e344","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"R7-20230924","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ccd.21700","article-title":"Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry.","volume":"72","author":"Kim","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R8-20230924","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1540-8183.2009.00495.x","article-title":"Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.","volume":"22","author":"Kim","year":"2009","journal-title":"J Interv Cardiol"},{"key":"R9-20230924","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1253\/circj.CJ-17-1173","article-title":"Determinants and long-term outcomes of percutaneous coronary interventions vs. surgery for multivessel disease according to clinical presentation.","volume":"82","author":"Hong","year":"2018","journal-title":"Circ J"},{"key":"R10-20230924","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl 1)","key":"R11-20230924","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"R12-20230924","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2016.06.020","article-title":"Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.","volume":"179","author":"Chang","year":"2016","journal-title":"Am Heart J"},{"key":"R13-20230924","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R14-20230924","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction.","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"R15-20230924","first-page":"87","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"R16-20230924","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes.","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-20230924","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"R18-20230924","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R19-20230924","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0735-1097(01)01183-4","article-title":"New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.","volume":"37","author":"Ledru","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R20-20230924","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"R21-20230924","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.jacc.2017.10.029","article-title":"Surgical versus percutaneous coronary revascularization in patients with diabetes and acute coronary syndromes.","volume":"70","author":"Ramanathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R22-20230924","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCIMAGING.112.973701","article-title":"Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study.","volume":"5","author":"Kato","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"R23-20230924","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cjca.2018.02.020","article-title":"The potential effects of new stent platforms for coronary revascularization in patients with diabetes.","volume":"34","author":"Guandalini","year":"2018","journal-title":"Can J Cardiol"},{"key":"R24-20230924","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCINTERVENTIONS.114.001346","article-title":"Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?.","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:04:48Z","timestamp":1695539088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000767","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}